BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19506354)

  • 21. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M
    Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis.
    Hassenpflug WA; Budde U; Obser T; Angerhaus D; Drewke E; Schneppenheim S; Schneppenheim R
    Blood; 2006 Mar; 107(6):2339-45. PubMed ID: 16322474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).
    Goodeve A; Eikenboom J; Castaman G; Rodeghiero F; Federici AB; Batlle J; Meyer D; Mazurier C; Goudemand J; Schneppenheim R; Budde U; Ingerslev J; Habart D; Vorlova Z; Holmberg L; Lethagen S; Pasi J; Hill F; Hashemi Soteh M; Baronciani L; Hallden C; Guilliatt A; Lester W; Peake I
    Blood; 2007 Jan; 109(1):112-21. PubMed ID: 16985174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C2362F mutation gives rise to an ADAMTS13-resistant von Willebrand factor.
    Casonato A; Pontara E; Battiston M; Morpurgo M; Cattini MG; Casarin E; Saga G; Daidone V; De Marco L
    Thromb Haemost; 2013 Jun; 109(6):999-1006. PubMed ID: 23446343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autosomal recessive von Willebrand disease type 1 or 2 due to homozygous or compound heterozygous mutations in the von Willebrand factor gene. A single center experience on molecular heterogeneity and laboratory features in 12 families.
    Castaman G; Giacomelli S; Rodeghiero F
    Acta Haematol; 2009; 121(2-3):106-10. PubMed ID: 19506356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.
    Yadegari H; Driesen J; Pavlova A; Biswas A; Hertfelder HJ; Oldenburg J
    Thromb Haemost; 2012 Oct; 108(4):662-71. PubMed ID: 22871923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of the loss of intrachain- versus interchain-disulfide bonds in the cystine-knot domain of von Willebrand factor on the clinical phenotype of von Willebrand disease.
    Tjernberg P; Vos HL; Spaargaren-van Riel CC; Luken BM; Voorberg J; Bertina RM; Eikenboom JC
    Thromb Haemost; 2006 Dec; 96(6):717-24. PubMed ID: 17139364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of von Willebrand factor gene mutations in Korean von Willebrand disease patients.
    Song J; Choi JR; Song KS
    Korean J Lab Med; 2007 Jun; 27(3):169-76. PubMed ID: 18094571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in von Willebrand factor multimerization domains are not a common cause of classical type 1 von Willebrand disease.
    Keeney S; Cumming A; Hay C
    Thromb Haemost; 1999 Nov; 82(5):1446-50. PubMed ID: 10595636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes.
    Lethagen S; Hillarp A; Ekholm C; Mattson E; Halldén C; Friberg B
    Thromb Haemost; 2008 Jun; 99(6):1013-8. PubMed ID: 18521502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
    Michiels JJ; Gadisseur A; Budde U; Berneman Z; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13.
    Bowen DJ; Collins PW
    Blood; 2004 Feb; 103(3):941-7. PubMed ID: 14525793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homozygous C2362F von Willebrand factor induces intracellular retention of mutant von Willebrand factor resulting in autosomal recessive severe von Willebrand disease.
    Tjernberg P; Castaman G; Vos HL; Bertina RM; Eikenboom JC
    Br J Haematol; 2006 May; 133(4):409-18. PubMed ID: 16643449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Y/C1584 mutation of von Willebrand factor in type 2M von Willebrand disease: frequency and clearance of von Willebrand factor.
    Millar CM; Riddel AF; Griffioe A; Jenkin PV; Brown SA
    Br J Haematol; 2005 Aug; 130(3):462-3. PubMed ID: 16042701
    [No Abstract]   [Full Text] [Related]  

  • 35. von Willebrand factor variant p.Arg924Gln marks an allele associated with reduced von Willebrand factor and factor VIII levels.
    Hickson N; Hampshire D; Winship P; Goudemand J; Schneppenheim R; Budde U; Castaman G; Rodeghiero F; Federici AB; James P; Peake I; Eikenboom J; Goodeve A;
    J Thromb Haemost; 2010 Sep; 8(9):1986-93. PubMed ID: 20492463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Getting at the variable expressivity of von Willebrand disease.
    Levy G; Ginsburg D
    Thromb Haemost; 2001 Jul; 86(1):144-8. PubMed ID: 11487001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand disease.
    Lanke E; Kristoffersson AC; Philips M; Holmberg L; Lethagen S
    Thromb Haemost; 2008 Aug; 100(2):211-6. PubMed ID: 18690339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autosomal recessive von Willebrand disease associated with compound heterozygosity for a novel nonsense mutation (2908 del C) and the missense mutation C2362F: definite evidence for the non-penetrance of the C2362F mutation.
    Castaman G; Bertoncello K; Bernardi M; Eikenboom JC; Budde U; Rodeghiero F
    Am J Hematol; 2007 May; 82(5):376-80. PubMed ID: 17109387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study.
    James PD; Notley C; Hegadorn C; Leggo J; Tuttle A; Tinlin S; Brown C; Andrews C; Labelle A; Chirinian Y; O'Brien L; Othman M; Rivard G; Rapson D; Hough C; Lillicrap D
    Blood; 2007 Jan; 109(1):145-54. PubMed ID: 17190853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A/IIE.
    Schneppenheim R; Michiels JJ; Obser T; Oyen F; Pieconka A; Schneppenheim S; Will K; Zieger B; Budde U
    Blood; 2010 Jun; 115(23):4894-901. PubMed ID: 20351307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.